(Q36097750)

12 August 2017

1 reference

title

Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era. (English)

1 reference

12 August 2017

1 reference

acute myeloid leukemia

1 reference

Alonzo TA

1

1 reference

12 August 2017

Wells RJ

2

1 reference

12 August 2017

Woods WG

3

1 reference

12 August 2017

Lange B

4

1 reference

12 August 2017

Gerbing RB

5

1 reference

12 August 2017

Buxton AB

6

1 reference

12 August 2017

Neudorf S

7

1 reference

12 August 2017

Sanders J

8

1 reference

12 August 2017

Smith FO

9

1 reference

12 August 2017

Feig SA

10

1 reference

12 August 2017

language of work or name

1 reference

1 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

19

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

965-970

1 reference

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a European view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

All-trans-retinoic acid in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an American view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

Definition of a standard-risk group in children with AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

7 January 2021

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

7 January 2021

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403763

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403763

1 reference

Dimensions Publication ID

12 August 2017

1012980433

0 references

1 reference